Please assess the completion status of the following clinical trial:

Trial Title: Dopamine in Orthostatic Tolerance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Upright plasma norepinephrine \> 600 pg/ml, or~* An increase in heart rate of \> 30 beats per minute upon standing, and~* Withdrawal of all medications for at least 3 days, and~* No associated medical illness, and~* Age 18 - 60 years old.~Exclusion Criteria:~* Older than 60 years of age~* Routinely taking medications affecting the autonomic nervous system~* Any chronic illness (cardiac, pulmonary, endocrine, gastrointestinal, rheumatologic) other than POTS~* Anemia (Hct \< 30)~* Women of childbearing age who are pregnant or nursing~* Unable to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- A (Type: EXPERIMENTAL): 10 mEq/day dietary sodium
- B (Type: EXPERIMENTAL): 150 mEq/day dietary sodium
- C (Type: EXPERIMENTAL): 300 mEq/day dietary sodium

Based on this trial design, predict the completion outcome and termination type (if applicable).